Bliss 1967.
Study characteristics | ||
Methods |
Study objective: to assess different mattresses for preventing pressure sores Study design: randomised controlled trial Study grouping: parallel group Duration of follow‐up: treatment for 14 days and follow‐up assessments on the 16th day Number of arms: 2 Single centre or multi‐site: single centre Study start date and end date: not described Setting: geriatric unit |
|
Participants |
Baseline characteristics Inclusion criteria: all new patients with a Norton score of 7 or more, and all inpatients with a score 7 or more and still rising, provided they had no, or only superficial, trunk sores at the time Exclusion criteria: patients with severe sores of the trunk Sex (M:F): overall 27:56; large‐celled ripple bed 10:32; control 17:24 Age (years): overall mean 81.2; large‐celled ripple bed 80.4; control 82.1 Baseline skin status: mean baseline Norton score 10.5; free of existing severe ulcers (43 with superficial sore) Group difference: no difference in variables except for sex distributions Total number of participants: n = 83 (70 analysed) Unit of analysis: individuals Unit of randomisation (per patient): individuals |
|
Interventions |
Intervention characteristics Large‐celled ripple bed
Ordinary hospital mattress
|
|
Outcomes |
Proportion of participants developing a new pressure ulcer
Time to pressure ulcer development
Support‐surface‐associated patient comfort
All reported adverse events using allocated support surfaces
Health‐related quality of life (HRQOL)
Cost‐effectiveness
Outcomes that are not considered in this review but reported in trials:
|
|
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Quote: "In order to ensure that the distribution of subjects among the various regimens was as random as possible the experimental and control treatments were arranged in a rota. As patients were admitted to the trial they were allocated to the next treatment on the rota in order" Comment: unclear risk of bias because the sequence generation process is not described |
Allocation concealment (selection bias) | Unclear risk | Comment: no information provided |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Outcome group: ulcer incidence Comment: no information provided |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Outcome group: ulcer incidence Quote: "The record forms were all evaluated in a single session by one observer, each being masked in such a way that it was not possible to know to which patient or to which experimental regimen it referred" Comment: low risk of bias because the blinding of assessment is stated |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Outcome group: ulcer incidence Comment: unclear risk of bias because 7 of 42 in ripple bed and 6 of 41 in control group were excluded from analysis |
Selective reporting (reporting bias) | High risk | Comment: the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre‐specified. However, incidence outcome data among those with existing ulcers are not available. |
Other bias | Low risk | Comment: the study appears to be free of other sources of bias |